openPR Logo
Press release

Next Gen Immuno-Oncology Congress-USA will discuss advancements in cancer immunotherapy, clinical development of immune checkpoint inhibitors and neoantigen-based immunotherapy.

03-06-2018 10:01 AM CET | Health & Medicine

Press release from: Markets and Markets

MarketsandMarkets is proud to announce the Next Gen Immuno-Oncology Congress USA to be held on 21st and 22nd June 2018 in Philadelphia. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiome-derived immunotherapy and new paradigms in immune checkpoint inhibitors.

The two-day, three-stream congress will also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. This gathering of pharma/biopharma and academia professionals working in the field of Immuno-Oncology will highlight key topics like Neoantigen in personalized Cancer Immunotherapy, Immune Checkpoint Inhibitors and Combinations (PD-1, PD-L1, PD-L4), Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators), Neoantigen Discovery by Next-Generation Sequencing, Biomarkers and Cancer Vaccines, CAR-T cell therapy, Dendritic Cell Therapy, Microbiome in Cancer Immunotherapy (Targets and Challenges), Oncolytic viruses, Tumour associated Macrophages as treatment in IO, Technologies for personalized TCR engineered cancer immunotherapies and Tumour microenvironment.

The first day of the congress will emphasis on cellular therapy, immune checkpoint inhibitors, Developments in CAR-T cell therapy and combinational therapies with presentations from NIH - USA, GSK, Gritstone Oncology, Agenus, Incyte, University of Connecticut, and University of Pennsylvania.

Whereas the day 2 of the conference will be more focussed on cancer immunotherapies and personalised immunotherapies with presentations talking about Precision Immunology for targeted therapy, Biomarkers in Cancer Immunotherapy, neoantigens in cancer immunotherapy, clinical development of ICI combinations and more. Highlight of the conference will be the presentation of Stefan Gluck, Vice President, Global Medical Affairs at Celgene, USA on the day 2. HE will presenting on studies in pancreatic cancer with IO compounds shading a light on new concepts and data about the novel studies in Pancreatic cancer and their susceptibility to ICI in combination with Chemotherapy and other IO agents.

Apart from Dr. Gluck, the conference will also feature some of the great mind of Immuno-Oncology industry such as [add few important speaker names with their organisations] who will be delivering keynote presentations, brainstorming panel discussions and case studies will give the stakeholders an opportunity to discuss and understand the uses faced and comes up with solutions for the same.

The congress will be attended by professionals working in pharma, biotech and leading institutes in USA from the levels of CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group leaders, Clinicians, Professor, Assistant professors. The early registration of the conference is now available on the website or you can write to Amit Shelke at amit.shelke@marketsandmarkets.com for more details on speakers, sessions and presentations along with registration details.

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.

Tower B5, office 101, Magarpatta SEZ, Hadapsar, Pune-411013, India.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Gen Immuno-Oncology Congress-USA will discuss advancements in cancer immunotherapy, clinical development of immune checkpoint inhibitors and neoantigen-based immunotherapy. here

News-ID: 965080 • Views: 130

More Releases from Markets and Markets

Smart Farming Market is Growing Due to the Increasing Automation & Digitization …
The growth in the trends of mechanization in the agriculture industry, focus on livestock monitoring to improve the efficiency of farms, and governments’ support for modern agricultural techniques stimulate the global smart farming market. The North American and European regions are projected to dominate the global smart farming market during the forecast period. These regions are the largest markets for innovative technologies used for agriculture. Considering the huge opportunities in these
Demand for Precision Agriculture is Increasing Globally Due to Rising Demand for …
Precision Agriculture Market Outlook Precision agriculture uses new advanced technologies to increase crop yield and profitability while lowering the overall use of traditional agricultural inputs such as land, water, herbicides, and pesticides. Various technologies using global positioning systems (GPS), geographic information systems (GIS), remote sensing, and variable rate technology are used in precision agriculture to collect crucial data for crop health such as soil nutrient, soil moisture, and weather forecast. Thus,
Vertical Farming Market is Growing Due to the Growing Global Population & Reduci …
Vertical Farming Market Outlook Vertical farming is one of the most innovative and sustainable methods of agriculture, as it lowers the water requirement and helps save considerable space and other inputs. The major driving factors for the vertical farming systems market are the need for high-quality food with low environmental impact and limited usage of pesticides; frequent crop failures due to weather; increase in urban population; and growth in annual crop
Drone Farming Market is Growing Due to Rising Need to Reduce Environmental Costs …
Drone Farming Market Outlook An agriculture drone is an unmanned aerial vehicle applied to farming for monitor crop growth and enhance crop productivity. This bird’s eye view of the fields enables farmers to tackle issues about irrigation, pest attack, and soil variation. Drone farming is useful for a number of applications; these include crop monitoring, soil assessment, plant emergence and population, soil fertility, crop protection, harvest planning, irrigation, and drainage. There

All 5 Releases


More Releases for Oncology

International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated